Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Mallinckrodt
Colorcon
Dow

Last Updated: August 15, 2022

Investigational Drug Information for Cannabinol


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Cannabinol?

Cannabinol is an investigational drug.

There have been 54 clinical trials for Cannabinol. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2009.

The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Sclerosis. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Yale University, and Radboud University.

Recent Clinical Trials for Cannabinol
TitleSponsorPhase
Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine TreatmentUniversity of California, San DiegoPhase 2
Cannabinol Use in Patients With Insomnia DisorderUniversity of SydneyPhase 1/Phase 2
Cannabinol Use in Patients With Insomnia DisorderWoolcock Institute of Medical ResearchPhase 1/Phase 2

See all Cannabinol clinical trials

Clinical Trial Summary for Cannabinol

Top disease conditions for Cannabinol
Top clinical trial sponsors for Cannabinol

See all Cannabinol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Mallinckrodt
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.